Fmoc-L-Pen(Trt)-OH

Online Inquiry

CAT#CP25571
CAS201531-88-6
Synonyms/Alias201531-88-6;Fmoc-Pen(Trt)-OH;FMOC-S-TRITYL-L-PENICILLAMINE;(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-methyl-3-(tritylthio)butanoicacid;(2R)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-3-methyl-3-[(triphenylmethyl)sulfanyl]butanoicacid;Fmoc-pen(trt);SCHEMBL118262;CTK4E3419;MolPort-006-705-794;XSGMGAINOILNJR-PGUFJCEWSA-N;ACT10377;ANW-74539;MFCD00237388;ZINC71788116;AKOS015895566;RTX-012381;AK-48000;AN-30001;SC-26571;DB-038111;KB-254040;ST51052986;I06-1183;L-Valine,N-[(9H-fluoren-9-ylmethoxy)carbonyl]-3-[(triphenylmethyl)thio]-;(2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-methyl-3-tritylsulfanyl-butanoicacid
Chemical NameN-alpha-(9-Fluorenylmethyloxycarbonyl)-S-trityl-L-penicillamine, Fmoc-beta,beta-dimethyl-L-Cys(Trt)-OH
M.F/FormulaC39H35NO4S
M.W/Mr.613,78 g/mole
Quick Inquiry
×
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Customer Support & Price Inquiry

* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).

Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!

 Timonacic's chemical name, L-Syrosin-4, is a new anti-tumor drug that converts cancer cells into normal cells. E ...

 MEN 11270 (H-DArg-Arg-Pro-Hyp-Gly-Thi-c(Dab-Dtic-Oic-Arg)c(7γ-10α)) is a novel selective constrained peptide ant ...

 NFAT, the nuclear factor of activated T cells, is a family of transcription factors that play an important role ...

  Margatoxin (MgTX) is a 39 amino acid peptide with significant sequence homology to charybdotoxin (ChTX), and ha ...

 Myristoyl pentapeptide-7, a cosmetic peptide, is a synthetic peptide containing lysine and threonine residues, w ...

Contact Us

USA

Address:

Tel: |

Email:

Germany

Address:

Copyright © 2024 Creative Peptides. All rights reserved.